WWW.BOOK.DISLIB.INFO
FREE ELECTRONIC LIBRARY - Books, dissertations, abstract
 
<< HOME
CONTACTS



Pages:     | 1 |   ...   | 24 | 25 || 27 | 28 |   ...   | 34 |

«2013 Annual Report breakthrough technologies and services focused on Dear Fellow Shareholders, addressing specific customer and market needs. Several ...»

-- [ Page 26 ] --

As a result of the sale of the IDS and Photoflash businesses in fiscal year 2010, the Company concluded that the remaining operations within those foreign subsidiaries previously containing IDS and Photoflash operations did not require the same level of capital as previously required, and therefore the Company planned to repatriate approximately $250.0 million of previously unremitted earnings and provided for the estimated taxes on the repatriation of those earnings. The impact of this tax provision in fiscal year 2010 was an increase to the Company’s tax provision of $65.8 million in discontinued operations. The Company utilized existing tax attributes to minimize the cash taxes paid on the repatriation. As of January 1, 2012, the Company had completed the repatriation of the previously unremitted earnings of the IDS and Photoflash businesses, and reduced the recorded estimated tax liability associated with the repatriation by $6.7 million. This change in estimate was recorded as a credit to discontinued operations during fiscal year 2011.

As a result of the Caliper acquisition, the Company concluded in fiscal year 2011 that certain foreign operations did not require the same level of capital as previously expected, and therefore the Company planned to repatriate approximately $350.0 million of previously unremitted earnings and has provided for the estimated taxes on the repatriation of those earnings. As a result of the planned repatriation, the Company recorded an increase to the Company’s tax provision of $79.7 million in continuing operations in fiscal year 2011. The Company utilized tax attributes, primarily those acquired in the Caliper acquisition, to minimize the cash taxes paid on the repatriation. As of December 29, 2013, the Company had completed the repatriation of the $350.0 million of foreign earnings.

Taxes have not been provided on unremitted earnings of international subsidiaries that the Company considers indefinitely reinvested because the Company plans to keep these amounts indefinitely reinvested overseas except for instances where the Company can remit such earnings to the U.S. without an associated net tax cost. The Company’s indefinite reinvestment determination is based on the future operational and capital requirements. As of December 29, 2013, the amount of foreign earnings that the Company has the intent and ability to keep invested outside the U.S. indefinitely and for which no U.S. tax cost has been provided was approximately $607.0 million. It is not practical to calculate the unrecognized deferred tax liability on those earnings.

Note 7: Earnings Per Share Basic earnings per share was computed by dividing net income by the weighted-average number of common shares outstanding during the period less restricted unvested shares. Diluted earnings per share was computed by dividing net income by the weighted-average number of common shares outstanding plus all potentially dilutive common stock equivalents, primarily shares issuable upon the exercise of stock options using the treasury stock method. The following table reconciles the number of shares utilized in the earnings per share calculations for the

fiscal years ended:

–  –  –

Antidilutive securities include outstanding stock options with exercise prices and average unrecognized compensation cost in excess of the average fair market value of common stock for the related period. Antidilutive options were excluded from the calculation of diluted net income per share and could become dilutive in the future.

Note 8: Accounts Receivable, Net Accounts receivable were net of reserves for doubtful accounts of $30.2 million and $23.4 million as of December 29, 2013 and December 30, 2012, respectively.

–  –  –

Depreciation expense on property, plant and equipment for the fiscal years ended December 29, 2013, December 30, 2012 and January 1, 2012 was $38.1 million, $35.6 million and $30.9 million, respectively.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) Note 11: Marketable Securities and Investments

Investments as of December 29, 2013 and December 30, 2012 consisted of the following:

–  –  –

Marketable securities include equity and fixed-income securities held to meet obligations associated with the Company’s supplemental executive retirement plan and other deferred compensation plans. The Company has, accordingly, classified these securities as long-term.

The net unrealized holding gain and loss on marketable securities, net of deferred income taxes, reported as a component of other comprehensive income in stockholders’ equity, was a $0.01 million gain in fiscal year 2013 and $0.03 million gain in fiscal year 2012. The proceeds from the sales of securities and the related gains and losses are not material for any period presented.

Marketable securities classified as available for sale as of December 29, 2013 and December 30, 2012

consisted of the following:

–  –  –

Note 12: Goodwill and Intangible Assets, Net The Company tests goodwill and non-amortizing intangible assets at least annually for possible impairment.

Accordingly, the Company completes the annual testing of impairment for goodwill and non-amortizing intangible assets on the later of January 1 or the first day of each fiscal year. In addition to its annual test, the Company regularly evaluates whether events or circumstances have occurred that may indicate a potential impairment of goodwill or non-amortizing intangible assets.





As discussed in Note 23, the Company realigned its organization at the beginning of fiscal year 2013, which resulted in a change in the composition of the Company’s reporting units and reportable segments. The Company’s Informatics business, as well as its field service on products previously sold by the Company’s former Bio-discovery business, were moved from the Environmental Health segment into the Human Health NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) segment. The results reported for fiscal year 2013 reflect this new alignment of the Company’s operating segments. Financial information relating to fiscal years 2012 and 2011 has been retrospectively adjusted to reflect the changes to the operating segments. As a result of the realignment, the Company reallocated goodwill from the Environmental Health segment to the Human Health segment based on the relative fair value, determined using the income approach, of the businesses within the historical Environmental Health segment.

The change resulted in $215.7 million of goodwill being allocated from the Environmental Health segment to the Human Health segment.

The process of testing goodwill for impairment involves the determination of the fair value of the applicable reporting units. The test consists of a two-step process. The first step is the comparison of the fair value to the carrying value of the reporting unit to determine if the carrying value exceeds the fair value. The second step measures the amount of an impairment loss, and is only performed if the carrying value exceeds the fair value of the reporting unit. The Company performed its annual impairment testing for its reporting units as of January 1, 2013, its annual impairment date for fiscal year 2013, which was based on the change in the reporting structure.

The Company concluded based on the first step of the process that there was no goodwill impairment, and the fair value exceeded the carrying value by more than 30.0% for each reporting unit.

The Company has consistently employed the income approach to estimate the current fair value when testing for impairment of goodwill. A number of significant assumptions and estimates are involved in the application of the income approach to forecast operating cash flows, including markets and market share, sales volumes and prices, costs to produce, tax rates, capital spending, discount rate and working capital changes. Cash flow forecasts are based on approved business unit operating plans for the early years’ cash flows and historical relationships in later years. The income approach is sensitive to changes in long-term terminal growth rates and the discount rates. The long-term terminal growth rates are consistent with the Company’s historical long-term terminal growth rates, as the current economic trends are not expected to affect the long-term terminal growth rates of the Company. The long-term terminal growth rates for the Company’s reporting units ranged from 4.5% to 6.0% for the fiscal year 2013 impairment analysis. The range for the discount rates for the reporting units was 10.5% to 12.0%. Keeping all other variables constant, a 10.0% change in any one of the input assumptions for the various reporting units would still allow the Company to conclude, based on the first step of the process, that there was no impairment of goodwill.

The Company has consistently employed the relief from royalty model to estimate the current fair value when testing for impairment of non-amortizing intangible assets. The impairment test consists of a comparison of the fair value of the non-amortizing intangible asset with its carrying amount. If the carrying amount of a nonamortizing intangible asset exceeds its fair value, an impairment loss in an amount equal to that excess is recognized. In addition, the Company currently evaluates the remaining useful life of its non-amortizing intangible assets at least annually to determine whether events or circumstances continue to support an indefinite useful life. If events or circumstances indicate that the useful lives of non-amortizing intangible assets are no longer indefinite, the assets will be tested for impairment. These intangible assets will then be amortized prospectively over their estimated remaining useful lives and accounted for in the same manner as other intangible assets that are subject to amortization. The Company performed its annual impairment testing as of January 1, 2013, and concluded that there was no impairment of non-amortizing intangible assets.

As part of integrating the Company’s recent acquisitions, in the fourth quarter of fiscal year 2012, the Company decided that prospectively it would primarily focus on the PerkinElmer trade name. Accordingly, the Company undertook a review of certain of its trade names within its portfolio as part of a realignment of its marketing strategy. The process resulted in the Company determining that the lives of certain trade names that it intends to phase out should be shortened, and in certain cases non-amortizing trade names were determined to no longer be indefinite-lived. Accordingly, the Company tested the recoverability of these identified indefinite-lived and definite-lived intangibles and concluded that the fair values of certain trade name intangible assets were less NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) than the carrying amounts of those assets. For non-amortizing trade names the Company compared the fair values, which was determined using a relief from royalty method, to the carrying values, considering the revised useful lives. For amortizing trade names, the Company first determined if the undiscounted cash flows associated with the intangibles exceeded the carrying values. If the undiscounted cash flows did not exceed the carrying values, the Company determined the fair values of the trade names using a relief from royalty method, considering the revised useful lives. As a result, the remaining adjusted fair values of $6.1 million for trade names are being amortized over the period of time until the trade names are expected to be phased out, having weighted average remaining useful lives of 3 years.

Additionally during fiscal year 2012, the Company recorded an intangible asset impairment charge of $74.2 million which was equal to the excess of the carrying amounts of the intangible assets over the fair value of such assets. The Company recognized $73.4 million pre-tax impairment charges in the Human Health segment and also recognized $0.7 million pre-tax impairment charges in the Environmental Health segment.



Pages:     | 1 |   ...   | 24 | 25 || 27 | 28 |   ...   | 34 |


Similar works:

«Raine ADHD Study: Long-term outcomes associated with stimulant medication in the treatment of ADHD in children This research study is a collaboration between the Ministerial Implementation Committee for Attention Deficit Hyperactivity Disorder in Western Australia (MICADHD) and the Telethon Institute for Child Health Research (TICHR), with funding provided by the Western Australian Department of Health (DOH) Principal Researchers Grant Smith Collaboration for Applied Research and Evaluation...»

«Aus der Klinik für Infektiologie und Pneumologie der Medizinischen Fakultät Charité – Universitätsmedizin Berlin DISSERTATION Neue Strategien zur Prophylaxe und Therapie des Lungenversagens bei Beatmung und Pneumonie zur Erlangung des akademischen Grades Doctor medicinae (Dr. med.) vorgelegt der Medizinischen Fakultät Charité – Universitätsmedizin Berlin von Holger Christian Müller aus Braunschweig Neue Strategien zur Prophylaxe und Therapie des Lungenversagens bei Beatmung und...»

«Krankenversicherung in Chile Privatisierung führt zu Risikoselektion und hohen Patientenzahlungen von Jens Holst Arbeitsgruppe International Health Fakultät für Gesundheitswissenschaften Universität Bielefeld English Abstract More than twenty years after its radical market oriented reform, the Chilean health care system depicts serious equity and fairness problems. Private insurance companies have used ex-ante as well as ex-post risk selection to avoid the affiliation of poorer and older...»

«Emergency Support Function #8 – Public Health and Medical Services Annex ESF Coordinator: Support Agencies: Department of Health and Human Services Department of Agriculture Department of Commerce Department of Defense Primary Agency: Department of Energy Department of Homeland Security Department of Health and Human Services Department of the Interior Department of Justice Department of Labor Department of State Department of Transportation Department of Veterans Affairs Environmental...»

«Therapeutic in vitro and in vivo approach of influenza virus infection by simultaneous reduction of virus titre and cytokine expression through inhibition of virus-induced NF-B and RafMEK-ERK activation Inaugural Dissertation submitted to the Faculty of Medicine in partial fulfilment of the requirements for the PhD-Degree of the Faculties of Veterinary Medicine and Medicine of the Justus Liebig University Giessen by Pinto, Ana Ruth Jorge Portugal Machado of Lisbon, Portugal Giessen 2008 From...»

«A DREAM ENVISIONED: AFRICAN AMERICANS’ STRUGGLES AND EXPERIENCES TOWARD SUCCESS IN HIGHER EDUCATION IN HEALTH RELATED AND NON-HEALTH RELATED DISCIPLINES A dissertation submitted by Hallie R. Harper to College of Saint Mary in partial fulfillment of the requirement for the degree of DOCTOR IN EDUCATION With an emphasis on Health Professions Education February 2, 2009 Omaha, NE 68104 UMI Number: 3360177 INFORMATION TO USERS The quality of this reproduction is dependent upon the quality of the...»

«U.S. Department of Justice Office of the Inspector General Evaluation and Inspections Division The Federal Bureau of Prisons’ Compassionate Release Program April 2013 In the Sentencing Reform Act of 1984, Congress authorized the Director of the Federal Bureau of Prisons (BOP) to request that a federal judge reduce an inmate’s sentence for “extraordinary and compelling” circumstances.1 Under the statute, the request can be based on either medical or non-medical conditions that could not...»

«Dental Assisting Program Information/Application Guide for 2016-2017 San Diego Mesa College rev. 10/2015 Must be submitted on or after Dec. 1, 2015 and no later than March 25, 2016 Job Title Program website Dental Assistant www.sdmesa.edu/dental-assisting Job Description Dental Assistants are skilled members of the allied dental health care team, assisting dentists in all dental procedures. They may be licensed by the State as a Registered Dental Assistant (RDA) to perform direct patient care...»

«27 March 2012 EMA/HMPC/143183/2010 Committee on Herbal Medicinal Products (HMPC) Assessment report on Lavandula angustifolia Miller, aetheroleum and Lavandula angustifolia Miller, flos Based on Article 16d(1), Article 16f and Article 16h of Directive 2001/83/EC as amended (traditional use) Final Herbal substance(s) (binomial scientific name of Lavandula angustifolia Miller, flos the plant, including plant part) Herbal preparation(s)  Lavandulae aetheroleum Essential oil obtained by steam...»

«ENCLOSURE 3 Mental Health Services Act (MHSA) Capital Facilities and Technological Needs PROPOSED GUIDELINES For completing the Technological Needs Project Proposal FOR THE COUNTY’S THREE-YEAR PROGRAM AND EXPENDITURE PLAN March 18, 2008 Mental Health Services Act Technological Needs Project Proposal Table of Contents PART I. PURPOSE AND BACKGROUND Purpose Technology Goals Client and Family Empowerment Modernize and Transform Information Systems Standards PART II: FUNDING REQUIREMENTS...»





 
<<  HOME   |    CONTACTS
2016 www.book.dislib.info - Free e-library - Books, dissertations, abstract

Materials of this site are available for review, all rights belong to their respective owners.
If you do not agree with the fact that your material is placed on this site, please, email us, we will within 1-2 business days delete him.